Home
Chairman & Independent Directo
Company Sec. & Compli. Officer
Whole Time Director
Whole Time Director
Independent Director
NSE: EMCURE
Share Price
Date | Price (₹) |
---|---|
15 Jan 2025 | 1363 |
14 Jan 2025 | 1351.45 |
13 Jan 2025 | 1315.7 |
10 Jan 2025 | 1355.35 |
09 Jan 2025 | 1433.1 |
08 Jan 2025 | 1450.05 |
07 Jan 2025 | 1418.15 |
06 Jan 2025 | 1425.3 |
03 Jan 2025 | 1463.45 |
02 Jan 2025 | 1478.35 |
Market Cap
25,819 Cr
EPS
30.3
P/E Ratio (TTM)
45.0
P/B Ratio (TTM)
6.3
Day’s High
1384.05
Day’s Low
1340.5
DTE
0.3
ROE
13.8
52 Week High
1577.5
52 Week Low
1226.5
ROCE
18.7
1M
1Y
3Y
5Y
Emcure Pharmaceuticals has received upgrade in credit ratings from CRISIL for bank facilities of Rs
Read more
13 Aug 2024
Emcure Pharmaceuticals announced that CARE Ratings has upgraded the credit ratings assigned to bank
Read more
13 Aug 2024
Net profit of Emcure Pharmaceuticals rose 10.48% to Rs 144.08 crore in the quarter ended June 2024 a
Read more
14 Aug 2024
Emcure Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 13 August 202
Read more
10 Aug 2024